Related Experiment Video
Updated: Aug 18, 2026

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
Prevalence of methylphenidate use among adolescents in Ontario
Abstract:
Despite a growing interest in the use of methylphenidate (Ritalin) to treat attention deficit/hyperactivity disorders, prevalence data has been scarce in Canada. A probability school survey conducted in 1997 among Ontario students in grades 7, 9, 11 and 13 is used to collect data on such use. Overall, 3.4% of students (5.3% of males, 1.7% of females) used methylphenidate in the previous year. Rates and patterns are similar to those found in the United States. Future research needs to examine reasons and correlates of use, extent of medical supervision and possible non-medical use of methylphenidate.
More Related Videos
10:02Event Related Potentials (ERPs) and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)
Published on: March 12, 2020
07:51Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
Published on: August 1, 2025
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Abuse and Addiction: Pharmacological Phenomena
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.